Comment on “Sodium glucose cotransporter 2 inhibitors and gout risk”

被引：0
|
作者：
Shih-Wei Lai
Bing-Fang Hwang
Chiu‑Shong Liu
Kuan-Fu Liao
机构：
[1] China Medical University,College of Medicine
[2] China Medical University Hospital,Department of Family Medicine
[3] China Medical University,Department of Occupational Safety and Health, College of Public Health
[4] Tzu Chi University,College of Medicine
[5] Taichung Tzu Chi Hospital,Division of Hepatogastroenterology, Department of Internal Medicine
来源：
Clinical Rheumatology | 2024年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：835 / 836
页数：1
相关论文
共 50 条
  • [1] Sodium glucose cotransporter 2 inhibitors and gout risk
    Lai, Shih-Wei
    Hwang, Bing-Fang
    Liu, Chiu-Shong
    Liao, Kuan-Fu
    CLINICAL RHEUMATOLOGY, 2024, 43 (02) : 835 - 836
  • [2] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (02): : 190 - 191
  • [3] Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis
    Wood, David T.
    Waterbury, Nancee V.
    Lund, Brian C.
    CLINICAL RHEUMATOLOGY, 2023, 42 (09) : 2469 - 2475
  • [4] Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis
    David T. Wood
    Nancee V. Waterbury
    Brian C. Lund
    Clinical Rheumatology, 2023, 42 : 2469 - 2475
  • [5] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [6] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [7] Sodium–glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kasper B. Kristensen
    Daniel P. Henriksen
    Jesper Hallas
    Anton Pottegård
    Lars C. Lund
    Diabetologia, 2021, 64 : 1563 - 1571
  • [8] The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout
    Chio Yokose
    Natalie McCormick
    Abhishek Abhishek
    Nicola Dalbeth
    Tristan Pascart
    Frédéric Lioté
    Angelo Gaffo
    John FitzGerald
    Robert Terkeltaub
    Meghan E. Sise
    James L. Januzzi
    Deborah J. Wexler
    Hyon K. Choi
    Nature Reviews Rheumatology, 2024, 20 : 216 - 231
  • [9] Lowering the risk of gout: Another benefits from the use of sodium-glucose cotransporter 2 inhibitors
    Sheu, Wayne H-H
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (05) : 1115 - 1116
  • [10] Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
    Arnott, Clare
    Fletcher, Robert A.
    Neal, Bruce
    HEART FAILURE CLINICS, 2022, 18 (04) : 645 - 654
12345